ストックスクリーナーアプリを入手
0.5379
1.30%
-0.0071
アフターアワーズ：
.54
0.0021
+0.39%
Evogene Ltd (EVGN) 最新ニュース
Casterra announces $2.2 Mn of purchase orders to supply castor seeds - AgroSpectrum India
Evogene (NASDAQ: EVGN) Share Price, EVGN Stock News, EVGN Share Price & Updates - Kalkine
Evogene Ltd. Approves Board Appointments - marketscreener.com
Evogene (EVGN) sets seven-member board after 2026 shareholder vote - Stock Titan
Evogene stock trades lower as biotech investors eye latest pipeline moves - AD HOC NEWS
L.I.A. Pure Capital Acquires 19.35% Activist Stake in Evogene (NASDAQ: EVGN) - Kalkine Media
L.I.A. Pure Capital Takes 19.35% Activist Stake in Evogene (NASDAQ: EVGN), Pushes for Board Changes - Kalkine Media
Evogene Ltd. (EVGN) stock price, news, quote and history - au.finance.yahoo.com
Evogene urges shareholders to support current b... - pluang.com
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward - tradingview.com
Evogene stock holds steady as investors eye latest genomics progress - AD HOC NEWS
Evogene (EVGN) investor group pushes for board seats at annual meeting - Stock Titan
L.I.A. Pure Capital Issues Response to Evogene - marketscreener.com
[6-K] Evogene Ltd. Current Report (Foreign Issuer) - Stock Titan
ISS and Glass Lewis back Evogene board nominees ahead of vote - Investing.com Canada
Evogene (EVGN) Q2 2026 Earnings Call Transcript - The Globe and Mail
Evogene Ltd (EVGN) Stock News Today - TradingKey
Evogene (EVGN) Momentum: Ends Higher by 3.14% at $0.60 on the Day; Next Session: $0.57 and $0.63 Define the Nearby Reference Levels for the Current SessionMoney Flow - dars.gov.et
Evogene Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Evogene | 6-K: Report of foreign private issuer (related to financial reporting) - Moomoo
Evogene earnings beat by $0.15, revenue topped estimates - Investing.com India
Evogene Q2 2026 Deep Dive: EPS Beats, Revenue Down 35% - AlphaStreet
Teleconferência de Resultados do 2T26 da Evogene (EVGN): Prejuízo Diminui com Expansão da ChemPass AI - TradingKey
Evogene Q2 2026: Loss Narrows 50.0% to -$0.14/Share, Revenue Down 35% - AlphaStreet
Earnings call transcript: Evogene narrows Q2 2026 loss as shares fall 7.8% - Investing.com Nigeria
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation - Global Agriculture
EVGN: Q2 net loss down 62% year-over-year as AI-driven focus delivers operational and financial gains - TradingView
EVGN: Q2 2026 net loss fell 62% year-over-year as AI-driven transformation boosted efficiency - TradingView
Evogene: Q2 Earnings Snapshot - theheraldreview.com
Evogene Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Evogene Q2 Results: EPS misses estimate, sales fall 61% YoY - scanx.trade
Evogene Q2 2026 Earnings: Net Loss Narrows Despite Lower Revenue - TradingKey
Evogene Reports Second Quarter and First Half 2026 Financial Results - PR Newswire
EVOGENE ($EVGN) Releases Q2 2026 Earnings - Moomoo
Evogene (EVGN) cuts staff to 38 as it overhauls into AI-driven chemistry - Stock Titan
Earnings To Watch: Evogene Ltd (EVGN) Q2 2026 -- GF Value Sees 15% Downside - Yahoo Finance
Freightos Names Yaron Eldad as Chief Financial Officer - marketscreener.com
EVGN Q2'26 Earnings: EPS estimate is (0.27) USD - TradingView
Armistice Capital (EVGN) discloses 4.99% beneficial stake in Evogene shares - Stock Titan
Evogene chairman to address dissident shareholder issues in Aug 18 earnings call - Pluang
Evogene Chairman Joins Company Results Call on August 18 - Stock Titan
Why Did EVGN Shares Drop More Than 14% Today? - Stocktwits
Evogene Ltd. (EVGN) investors lift beneficial stake to 19.35% of shares - Stock Titan
Evogene (EVGN): Director Leon Recanati buys 460,000 shares, now holds 8.6% - Stock Titan
Evogene | SCHEDULE 13D/A: Others - Moomoo
Evogene | 4: Statement of changes in beneficial ownership of securities-Director RECANATI LEON - Moomoo
Evogene (EVGN) director Leon Recanati buys 460,000 shares and reports option holdings - Stock Titan
Earnings Preview: Evogene to Report Financial Results Pre-market on August 18 - Moomoo
Leon Recanati Discloses Investment at Evogene Ltd. with 5.7% Stake - TradingView
Evogene (EVGN) director Leon Recanati buys 800,000 shares, lifts stake to 5.7% - Stock Titan
Evogene Ltd. (EVGN) investor group boosts ownership to 15.98% - Stock Titan
Evogene Ltd (EVGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ICL to acquire the activity of Evogene's subsidiary, Lavie Bio - AgroSpectrum India
Evogene Ltd. (EVGN) director boosts stake with 800,000-share buy - Stock Titan
ICL and Lavie Bio leverage AI for the development of yield increasing Bio-Stimulants - AgroSpectrum India
Evogene Sets Sept. 4 AGM Amid Board Contest and VP Departure - The Globe and Mail
Evogene Ltd. Revenue Breakdown – NASDAQ:EVGN - TradingView
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):